Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Verve Therapeutics, Inc. ("Verve Therapeutics" or the "Company") (NASDAQ: VERV) investors of a class action representing investors that bought securities August 9, 2022 and April 1, 2024, inclusive (the "Class Period"). Verve Therapeutics investors have until October 28, 2024 to file a lead plaintiff motion. Investors are encouraged to contact ...